Increased mortality in children with severe trauma and bleeding: Hypotheses and methods to reduce the risk

Le résumé fourni par la source

PCS consults for Cerus, is on the scientific advisory board for Haima, Octapharma, and Griffols, and is co-founder and Chief Medical Officer for Kalocyte. The opinions and assertions expressed herein are those of the author(s) and do not reflect the official policy or position of the Uniformed Services University of the Health Sciences or the Department of War. No primary datasets were generated during this study. This commentary is based on analysis of publicly available literature.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.